STOCK TITAN

Annexon Biosciences to Present at the Bank of America Health Care Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Annexon, a biopharmaceutical company, will present at the Bank of America Health Care Conference. President and CEO, Douglas Love, will discuss the company's late-stage clinical platform for neuroinflammatory diseases. The event will be live-streamed on May 14, 2024, at 8:40 a.m. PT.

Positive
  • None.
Negative
  • None.

BRISBANE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye, today announced that Douglas Love, president and chief executive officer, will present at the Bank of America Health Care Conference on Tuesday, May 14, 2024 at 8:40 a.m. PT.

A live webcast of the event can be accessed under the ‘Events & Presentations’ section on the Investors page at www.annexonbio.com. A replay of the webcast will be archived on the Annexon website for 30 days following the presentation.

About Annexon

Annexon Biosciences (Nasdaq: ANNX) is a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical complement-mediated neuroinflammatory diseases of the body, brain, and eye. Annexon’s novel scientific approach targets upstream C1q to block the classical complement inflammatory cascade before it starts, and its therapeutic candidates are designed to provide meaningful benefits across multiple autoimmune, neurodegenerative and ophthalmic diseases. With proof-of concept data in Guillain-Barré syndrome, Huntington’s disease and geographic atrophy, Annexon is rigorously advancing its mid-to late-stage clinical trials to bring new potential treatments to patients as quickly as possible. To learn more visit annexonbio.com.

Investor Contact:
Joyce Allaire
LifeSci Advisors, LLC
jallaire@lifesciadvisors.com

Media Contact:
Sheryl Seapy
Real Chemistry
949-903-4750
sseapy@realchemistry.com


FAQ

What is Annexon presenting at the Bank of America Health Care Conference?

Annexon will present its late-stage clinical platform of novel therapies for neuroinflammatory diseases.

Who will be presenting for Annexon at the conference?

Douglas Love, the president and chief executive officer, will present.

When will the presentation take place?

The presentation will be on Tuesday, May 14, 2024, at 8:40 a.m. PT.

Where can I watch the live webcast of the event?

The live webcast can be accessed on the 'Events & Presentations' section of the Investors page at www.annexonbio.com.

How long will the webcast be available for viewing after the presentation?

A replay of the webcast will be archived on the Annexon website for 30 days.

Annexon, Inc.

NASDAQ:ANNX

ANNX Rankings

ANNX Latest News

ANNX Stock Data

765.99M
105.65M
0.39%
104.55%
8.44%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
BRISBANE